Form: CORRESP

Correspondence

April 11, 2025

VOLITIONRX LIMITED

1489 West Warm Springs Road, Suite 110

Henderson, Nevada  89014

 

April 11, 2025

 

SUBMITTED VIA EDGAR

 

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 

Attention: Tyler Howes

 

 

Re:

VolitionRx Limited Acceleration Request

Registration Statement on Form S-1

Filed April 4, 2025

File No. 333-286401

 

 

 

 

Requested Date: April 15, 2025

Requested Time: 5:00 P.M. Eastern Time

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 of the Securities Act of 1933, as amended, VolitionRx Limited, a Delaware corporation (the “Company”), hereby respectfully requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to declare the above-captioned Registration Statement on Form S-1 effective as of the “Requested Date” and “Requested Time” set forth above, or as soon thereafter as practicable.

 

Should the Commission have any questions regarding this acceleration request, please do not hesitate to contact Marc G. Alcser, an attorney with the Company’s outside legal counsel, Stradling Yocca Carlson & Rauth LLP, via telephone at (949) 725-4136 or via email at malcser@stradlinglaw.com.  We respectfully request that you contact Mr. Alcser via telephone as soon as the above referenced Registration Statement has been declared effective.

 

 

Sincerely,

 

VOLITIONRX LIMITED

 

/s/ Cameron Reynolds

 

Cameron Reynolds

President and Chief Executive Officer

 

cc:

 

VolitionRx Limited

Terig Hughes, Chief Financial Officer

 

Stradling Yocca Carlson & Rauth LLP

Marc G. Alcser, Esq.